Offsets

May 04, 2026

USD ($)

Offset: 1

Offset Payment:

Offset Claimed

true

Rule 457(p) Offset

true

Registrant or Filer Name

Biohaven Ltd.

Form or Filing Type

S-3

File Number

333-274822

Initial Filing Date

Oct. 02, 2023

Fee Offset Claimed

$ 17,519.09

Security Type Associated with Fee Offset Claimed

Equity

Security Title Associated with Fee Offset Claimed

Common Shares, no par value per share

Unsold Aggregate Offering Amount Associated with Fee Offset Claimed

$ 118,693,000

Offset Note

The registrant previously registered the offer, sale and issuance of common shares having an aggregate offering price of up to $300,000,000 by means of a prospectus supplement filed pursuant to Rule 424(b)(5) under the Securities Act on August 16, 2024 (the “prior prospectus supplement”), pursuant to the Company’s registration statement on Form S-3 (File No. 333-274822), filed on October 2, 2023 (the “2023 Registration Statement”), with the Securities and Exchange Commission. In connection with the filing of the prior prospectus supplement, the registrant paid filing fees of $44,280.00. As of the date of this prospectus supplement, common shares having an aggregate offering price of $118,693,000.00 remain unsold under the prior prospectus supplement. Pursuant to Rule 457(p), $17,519.09 of the filing fee previously paid with respect to the unsold securities under the prior prospectus supplement is being applied to the filing fee payable with respect to this prospectus supplement. The registrant has completed the offering that included the unsold common shares under the prior prospectus supplement and the 2023 Registration Statement.

Termination / Withdrawal Statement

The registrant previously registered the offer, sale and issuance of common shares having an aggregate offering price of up to $300,000,000 by means of a prospectus supplement filed pursuant to Rule 424(b)(5) under the Securities Act on August 16, 2024 (the “prior prospectus supplement”), pursuant to the Company’s registration statement on Form S-3 (File No. 333-274822), filed on October 2, 2023 (the “2023 Registration Statement”), with the Securities and Exchange Commission. In connection with the filing of the prior prospectus supplement, the registrant paid filing fees of $44,280.00. As of the date of this prospectus supplement, common shares having an aggregate offering price of $118,693,000.00 remain unsold under the prior prospectus supplement. Pursuant to Rule 457(p), $17,519.09 of the filing fee previously paid with respect to the unsold securities under the prior prospectus supplement is being applied to the filing fee payable with respect to this prospectus supplement. The registrant has completed the offering that included the unsold common shares under the prior prospectus supplement and the 2023 Registration Statement.

Offset: 2

Offset Payment:

Offset Claimed

false

Rule 457(p) Offset

true

Registrant or Filer Name

Biohaven Ltd

Form or Filing Type

S-3

File Number

333-274822

Filing Date

Aug. 16, 2024

Fee Paid with Fee Offset Source

$ 44,280